|
Pfizer 辉瑞制药有限公司 Taking its medicine. 自尝苦果。 A drug giant coughs up to settle bribery charges. 一个制药巨头被迫出钱就撤销行贿指控与司法部达成和解。 IN AMERICA, it was once common for drug firms tooffer doctors perks to encourage them toprescribe their pills. Regulators now frown onsuch iffy sales techniques, and drug firms have more or less stopped using them. But inemerging markets, it is a different story, as a settlement on August 7th between America sDepartment of Justice and Pfizer, a big American drug firm, made clear. 在美国，制药公司给医生 回扣 鼓励他们开处方时使用该公司生产的药物曾是很常见的事。现在相关管理部门开始禁止这样不规范的销售技巧，因此一些制药公司也或多或少不再使用这种技巧。8 月7日，美国大型制药公司辉瑞就海外贿赂行为与美国司法部达成了和解。此事正好表明新兴市场的情况与美国的有所不同。 In China Pfizer established a club that provided high-prescribing doctors with all kinds ofentertainment under the guise of attending conferences. In Kazakhstan Pfizer awarded anexclusive distribution deal to a local firm after it was told there was no other way tosecure government approval for a Pfizer product. | 
